Crinetics announced findings from the PATHFNDR-1 trial showing the investigative oral daily drug may provide patients with the rare disease an alternative from recurring injection therapy.
250 Pages Acromegaly Treatment Market Survey by Fact MR, A Leading Business and Competitive Intelligence ProviderThe rising awareness about acromegaly and an increase in the rates of screening are among the prime driver of the acromegaly treatment market. Moreover, advancements in surgery and growing alternatives, s.
A new study on the Acromegaly Treatment Market makes a detailed assessment of current opportunities, upcoming revenue areas, and current and projected valuations of various segments in the market, gauging the economic impact of COVID-19. The assessments that span several pages include identifying key growth drivers,.